[HTML][HTML] The role and mechanism of flavonoid herbal natural products in ulcerative colitis

JC Xue, S Yuan, H Meng, XT Hou, J Li… - Biomedicine & …, 2023 - Elsevier
Ulcerative colitis (UC) is a chronic inflammatory disease of the intestine that presents
clinically with abdominal pain, mucopurulent stools, and posterior urgency. The lesions of …

Inflammation-driven colorectal cancer associated with colitis: from pathogenesis to changing therapy

OM Nardone, I Zammarchi, G Santacroce, S Ghosh… - Cancers, 2023 - mdpi.com
Simple Summary Patients with inflammatory bowel disease (IBD) are at an increased risk of
developing colorectal cancer (CRC), mainly because of chronic intestinal inflammation …

Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States

L Janker, D Schuster, P Bortel, G Hagn… - Journal of Crohn's …, 2023 - academic.oup.com
Introduction Ulcerative colitis [UC] is a chronic disease with rising incidence and unclear
aetiology. Deep molecular phenotyping by multiomics analyses may provide novel insights …

Personalized dietary regimens for inflammatory bowel disease: current knowledge and future perspectives

J Wellens, E Vissers, C Matthys… - Pharmacogenomics …, 2023 - Taylor & Francis
Inflammatory bowel diseases (IBD) are chronic and incurable conditions of the gastro-
intestinal tract with an increasing incidence and prevalence worldwide. Common symptoms …

Whole blood DNA methylation changes are associated with anti-TNF drug concentration in patients with Crohn's disease

S Lin, E Hannon, M Reppell, JF Waring… - Journal of Crohn's …, 2023 - academic.oup.com
Abstract Background and Aims Anti-tumour necrosis factor [TNF] treatment failure in patients
with inflammatory bowel disease [IBD] is common and frequently related to low drug …

Omics and Multi-Omics in IBD: No Integration, No Breakthroughs

C Fiocchi - International Journal of Molecular Sciences, 2023 - mdpi.com
The recent advent of sophisticated technologies like sequencing and mass spectroscopy
platforms combined with artificial intelligence-powered analytic tools has initiated a new era …

Precision medicine: how multiomics will shape the future of inflammatory bowel disease?

NZ Borren, AN Ananthakrishnan - Current opinion in …, 2022 - journals.lww.com
Precision medicine: how multiomics will shape the future of... : Current Opinion in
Gastroenterology Precision medicine: how multiomics will shape the future of inflammatory …

Profiling the use of complementary alternative medicines among inflammatory bowel disease patients: results from a single center survey

P Sudhakar, B Keersmaekers, R Stiers… - …, 2022 - Wiley Online Library
Background. Complementary and alternative medicines (CAMs) are used by patients with
chronic disorders, such as inflammatory bowel disease (IBD), with a desire to manage their …

Multi-Omics Characterization of Colon Mucosa and Submucosa/Wall from Crohn's Disease Patients

L Jin, M Macoritto, J Wang, Y Bi, F Wang… - International Journal of …, 2024 - mdpi.com
Crohn's disease (CD) is a subtype of inflammatory bowel disease (IBD) characterized by
transmural disease. The concept of transmural healing (TH) has been proposed as an …

Clinical value of multi-omics-based biomarker signatures in inflammatory bowel diseases: challenges and opportunities

AR Bourgonje, H van Goor, KN Faber… - Clinical and …, 2022 - journals.lww.com
Inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative
colitis (UC), are complex and heterogeneous diseases characterized by a multifactorial …